We are live on ! Find out more
PCH

PotlatchDeltic

Delisted

PCH was delisted on the 30th of January, 2026.

200 hedge funds and large institutions have $1.16B invested in PotlatchDeltic in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 80 increasing their positions, 62 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 13

29% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 62

10% more capital invested

Capital invested by funds: $1.06B → $1.16B (+$101M)

5% more funds holding

Funds holding: 190200 (+10)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0.52% less ownership

Funds ownership: 85.59%85.08% (-0.52%)

Holders
200
Holders Change
+10
Holders Change %
+5.26%
% of All Funds
5.33%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
26
Increased
80
Reduced
62
Closed
13
Calls
$11K
Puts
Net Calls
+$11K
Net Calls Change
-$288K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$143M +$25.8M +761,769 +22%
Vanguard Group
2
Vanguard Group
Pennsylvania
$103M +$4.72M +139,420 +5%
BFA
3
BlackRock Fund Advisors
California
$83.8M +$2.67M +78,921 +3%
PAMU
4
Pictet Asset Management (UK)
United Kingdom
$53.3M +$1.44M +42,673 +3%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$46.4M -$352K -10,400 -0.8%
State Street
6
State Street
Massachusetts
$43.8M +$101K +2,980 +0.2%
BIT
7
BlackRock Institutional Trust
California
$42.2M -$964K -28,496 -2%
Renaissance Technologies
8
Renaissance Technologies
New York
$41.5M -$1.08M -32,053 -3%
Fuller & Thaler Asset Management
9
Fuller & Thaler Asset Management
California
$34M +$5.73M +169,200 +20%
DRZID
10
DePrince Race & Zollo Inc (DRZ)
Florida
$31.6M -$8.55M -252,577 -21%
Baird Financial Group
11
Baird Financial Group
Wisconsin
$26.3M +$173K +5,118 +0.7%
Northern Trust
12
Northern Trust
Illinois
$25.7M +$4.74M +140,110 +23%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$23.7M +$6.15M +181,685 +35%
EA
14
Emerald Acquisition
Washington
$22.8M +$22.6M +667,233 New
JP Morgan Chase
15
JP Morgan Chase
New York
$22.3M -$754K -22,278 -3%
Victory Capital Management
16
Victory Capital Management
Texas
$18.4M -$618K -18,275 -3%
DIA
17
Denver Investment Advisors
Colorado
$17.5M +$15.2M +450,624 +734%
HA
18
Heartland Advisors
Wisconsin
$16.1M +$3.37M +99,460 +27%
KCM
19
Kennedy Capital Management
Missouri
$15.5M -$229K -6,781 -1%
Wells Fargo
20
Wells Fargo
California
$13.7M -$919K -27,156 -6%
Norges Bank
21
Norges Bank
Norway
$13M +$208K +6,139 +2%
OCA
22
Otter Creek Advisors
Florida
$12.8M +$1.86M +54,911 +17%
Ameriprise
23
Ameriprise
Minnesota
$11.8M +$2.35M +69,479 +25%
CAG
24
Crestwood Advisors Group
Massachusetts
$10.5M +$899K +26,554 +9%
CC
25
Cannell & Co
New York
$10.4M +$1.3M +38,350 +14%

PCH Hedge Fund Activity: Q2 2016 in Review

200 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in PotlatchDeltic (PCH) for Q2 2016, worth a combined $1.16B — up 9.5% from $1.06B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PCH positions and 13 closed out — a net gain of 13 holders — while 80 added to existing stakes and 62 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $25.8M. The largest seller was Perkins Investment Management, cutting an estimated $43.3M.

  • 200 institutional investors held PotlatchDeltic (PCH) as of Q2 2016, up from 190 in Q1 2016.
  • Funds reported $1.16B of PotlatchDeltic stock for Q2 2016, up 9.5% quarter-over-quarter.
  • 26 funds opened new PotlatchDeltic positions in Q2 2016 and 13 closed out, a net change of +13 holders.
  • The largest PotlatchDeltic buyer in Q2 2016 was Fidelity Investments, an estimated $25.8M added.
  • The largest PotlatchDeltic seller in Q2 2016 was Perkins Investment Management, an estimated $43.3M sold.

Based on aggregated 13F filings for Q2 2016.